 David Church
Concepts (205)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 24 | 2024 | 781 | 4.420 |
Why?
| | Muscle Proteins | 13 | 2024 | 320 | 3.470 |
Why?
| | Exercise | 20 | 2024 | 505 | 2.120 |
Why?
| | Resistance Training | 13 | 2020 | 93 | 2.080 |
Why?
| | Dietary Supplements | 15 | 2023 | 445 | 1.920 |
Why?
| | Amino Acids, Essential | 6 | 2024 | 133 | 1.470 |
Why?
| | Dietary Proteins | 8 | 2021 | 243 | 1.160 |
Why?
| | Amino Acids | 5 | 2023 | 373 | 1.140 |
Why?
| | Military Personnel | 5 | 2022 | 165 | 1.090 |
Why?
| | Carnosine | 4 | 2018 | 5 | 1.030 |
Why?
| | Aging | 5 | 2024 | 675 | 1.020 |
Why?
| | Protein Biosynthesis | 5 | 2020 | 253 | 1.000 |
Why?
| | Athletic Performance | 4 | 2020 | 31 | 0.940 |
Why?
| | beta-Alanine | 3 | 2018 | 9 | 0.890 |
Why?
| | Young Adult | 30 | 2024 | 4064 | 0.820 |
Why?
| | Muscle Contraction | 2 | 2019 | 111 | 0.750 |
Why?
| | Diet | 6 | 2023 | 554 | 0.670 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2016 | 138 | 0.660 |
Why?
| | Male | 41 | 2024 | 25718 | 0.650 |
Why?
| | Military Medicine | 1 | 2019 | 22 | 0.650 |
Why?
| | Stress, Physiological | 2 | 2019 | 174 | 0.640 |
Why?
| | Liver | 2 | 2024 | 1123 | 0.630 |
Why?
| | Muscular Atrophy | 1 | 2019 | 71 | 0.630 |
Why?
| | Occupational Diseases | 1 | 2019 | 82 | 0.620 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 1785 | 0.610 |
Why?
| | Leucine | 3 | 2023 | 118 | 0.600 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2021 | 263 | 0.570 |
Why?
| | Polyphenols | 4 | 2018 | 30 | 0.570 |
Why?
| | Cross-Over Studies | 10 | 2022 | 224 | 0.560 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2016 | 77 | 0.550 |
Why?
| | Triterpenes | 1 | 2016 | 11 | 0.530 |
Why?
| | Multiprotein Complexes | 1 | 2016 | 24 | 0.530 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2016 | 33 | 0.520 |
Why?
| | Humans | 50 | 2024 | 50389 | 0.510 |
Why?
| | Sarcopenia | 3 | 2021 | 94 | 0.500 |
Why?
| | Coffee | 1 | 2015 | 10 | 0.500 |
Why?
| | Double-Blind Method | 10 | 2021 | 682 | 0.500 |
Why?
| | Adult | 26 | 2024 | 13568 | 0.490 |
Why?
| | Reaction Time | 1 | 2015 | 215 | 0.480 |
Why?
| | Monocytes | 4 | 2018 | 131 | 0.440 |
Why?
| | Muscle Strength | 4 | 2020 | 128 | 0.420 |
Why?
| | Quadriceps Muscle | 3 | 2018 | 47 | 0.420 |
Why?
| | Phenylalanine | 3 | 2022 | 131 | 0.400 |
Why?
| | Postprandial Period | 3 | 2021 | 70 | 0.390 |
Why?
| | Valerates | 3 | 2017 | 38 | 0.390 |
Why?
| | Dietary Carbohydrates | 2 | 2024 | 90 | 0.360 |
Why?
| | Infant, Premature | 2 | 2024 | 319 | 0.360 |
Why?
| | Energy Metabolism | 2 | 2024 | 284 | 0.340 |
Why?
| | Cytokines | 3 | 2017 | 606 | 0.330 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 3 | 2017 | 40 | 0.320 |
Why?
| | Proteins | 2 | 2022 | 350 | 0.310 |
Why?
| | Paresthesia | 2 | 2018 | 8 | 0.300 |
Why?
| | Histidine | 2 | 2017 | 15 | 0.290 |
Why?
| | Eating | 4 | 2022 | 158 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2017 | 388 | 0.280 |
Why?
| | Meat | 2 | 2024 | 61 | 0.280 |
Why?
| | Fatigue | 2 | 2017 | 118 | 0.270 |
Why?
| | Female | 15 | 2024 | 26981 | 0.270 |
Why?
| | Exercise Test | 5 | 2019 | 130 | 0.270 |
Why?
| | Enteral Nutrition | 2 | 2024 | 149 | 0.260 |
Why?
| | Isometric Contraction | 4 | 2018 | 21 | 0.250 |
Why?
| | Insulin | 5 | 2021 | 466 | 0.240 |
Why?
| | Animals | 4 | 2024 | 13173 | 0.230 |
Why?
| | Athletes | 3 | 2020 | 98 | 0.230 |
Why?
| | Nandrolone | 1 | 2024 | 4 | 0.230 |
Why?
| | Cattle | 1 | 2024 | 208 | 0.230 |
Why?
| | Adolescent | 8 | 2024 | 6475 | 0.220 |
Why?
| | Digestion | 2 | 2020 | 29 | 0.220 |
Why?
| | Androgens | 1 | 2024 | 67 | 0.220 |
Why?
| | Anabolic Agents | 1 | 2024 | 37 | 0.220 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 36 | 0.210 |
Why?
| | Random Allocation | 1 | 2024 | 287 | 0.210 |
Why?
| | Proteolysis | 2 | 2020 | 96 | 0.210 |
Why?
| | Nutritional Status | 2 | 2023 | 136 | 0.210 |
Why?
| | Signal Transduction | 4 | 2020 | 1625 | 0.200 |
Why?
| | Chemokine CCL2 | 3 | 2018 | 68 | 0.200 |
Why?
| | Malnutrition | 1 | 2023 | 86 | 0.200 |
Why?
| | Body Mass Index | 4 | 2021 | 669 | 0.190 |
Why?
| | Food Analysis | 1 | 2021 | 26 | 0.190 |
Why?
| | Myocardium | 1 | 2024 | 444 | 0.180 |
Why?
| | Infusions, Intravenous | 1 | 2021 | 213 | 0.180 |
Why?
| | Metabolism | 1 | 2020 | 25 | 0.180 |
Why?
| | Actinidia | 1 | 2020 | 7 | 0.180 |
Why?
| | Running | 2 | 2020 | 16 | 0.180 |
Why?
| | Food | 1 | 2020 | 68 | 0.180 |
Why?
| | Muscle Fatigue | 2 | 2018 | 10 | 0.180 |
Why?
| | Caloric Restriction | 1 | 2020 | 34 | 0.170 |
Why?
| | Carbohydrate Metabolism | 1 | 2019 | 26 | 0.170 |
Why?
| | Adaptation, Physiological | 1 | 2020 | 92 | 0.170 |
Why?
| | Receptors, CCR2 | 2 | 2016 | 14 | 0.170 |
Why?
| | Alzheimer Disease | 1 | 2023 | 283 | 0.160 |
Why?
| | Testosterone | 4 | 2023 | 137 | 0.160 |
Why?
| | Physical Fitness | 2 | 2016 | 56 | 0.160 |
Why?
| | Hormones | 1 | 2019 | 57 | 0.160 |
Why?
| | Kidney | 1 | 2024 | 686 | 0.160 |
Why?
| | Kinetics | 1 | 2020 | 635 | 0.160 |
Why?
| | Proteome | 1 | 2020 | 159 | 0.160 |
Why?
| | Occupational Health | 1 | 2019 | 66 | 0.160 |
Why?
| | Patient Compliance | 2 | 2017 | 231 | 0.160 |
Why?
| | Football | 2 | 2016 | 72 | 0.150 |
Why?
| | Lactic Acid | 2 | 2016 | 75 | 0.150 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 55 | 0.150 |
Why?
| | Cognition | 2 | 2023 | 314 | 0.150 |
Why?
| | Martial Arts | 1 | 2017 | 1 | 0.150 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 14 | 0.150 |
Why?
| | Hand Strength | 1 | 2017 | 22 | 0.140 |
Why?
| | Glucose | 1 | 2019 | 341 | 0.140 |
Why?
| | Nutrition Assessment | 1 | 2017 | 64 | 0.140 |
Why?
| | Supine Position | 1 | 2016 | 28 | 0.140 |
Why?
| | Granulocytes | 1 | 2016 | 26 | 0.140 |
Why?
| | Postural Balance | 1 | 2017 | 58 | 0.140 |
Why?
| | Energy Intake | 3 | 2024 | 171 | 0.140 |
Why?
| | Physical Education and Training | 1 | 2016 | 24 | 0.140 |
Why?
| | Work Capacity Evaluation | 1 | 2016 | 21 | 0.140 |
Why?
| | Dietary Fats | 1 | 2017 | 126 | 0.140 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2016 | 29 | 0.140 |
Why?
| | Milk Proteins | 1 | 2017 | 77 | 0.140 |
Why?
| | Antioxidants | 1 | 2018 | 238 | 0.140 |
Why?
| | Patient Positioning | 1 | 2016 | 32 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 32 | 0.130 |
Why?
| | Hydrocortisone | 4 | 2017 | 107 | 0.130 |
Why?
| | Rest | 1 | 2016 | 60 | 0.130 |
Why?
| | Performance-Enhancing Substances | 1 | 2015 | 4 | 0.130 |
Why?
| | Plant Extracts | 1 | 2018 | 166 | 0.130 |
Why?
| | MAP Kinase Signaling System | 1 | 2016 | 118 | 0.130 |
Why?
| | Quality of Life | 1 | 2021 | 844 | 0.130 |
Why?
| | Caffeine | 1 | 2015 | 64 | 0.120 |
Why?
| | NF-kappa B | 1 | 2016 | 315 | 0.120 |
Why?
| | Ultrasonography | 1 | 2016 | 438 | 0.120 |
Why?
| | Body Composition | 3 | 2022 | 326 | 0.120 |
Why?
| | Postoperative Complications | 1 | 2021 | 1035 | 0.110 |
Why?
| | Heart Rate | 1 | 2015 | 311 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1356 | 0.110 |
Why?
| | Mice | 1 | 2024 | 5688 | 0.110 |
Why?
| | Blood Pressure | 1 | 2015 | 529 | 0.100 |
Why?
| | Blood Glucose | 1 | 2015 | 443 | 0.100 |
Why?
| | Aged | 4 | 2021 | 9590 | 0.100 |
Why?
| | Myoglobin | 3 | 2017 | 25 | 0.100 |
Why?
| | Time Factors | 4 | 2021 | 2934 | 0.100 |
Why?
| | Tyrosine | 2 | 2022 | 95 | 0.090 |
Why?
| | Middle Aged | 3 | 2021 | 12460 | 0.090 |
Why?
| | Risk Factors | 1 | 2019 | 3692 | 0.090 |
Why?
| | Meals | 2 | 2021 | 54 | 0.090 |
Why?
| | Oxygen Consumption | 2 | 2020 | 189 | 0.080 |
Why?
| | Macrophage-1 Antigen | 2 | 2018 | 6 | 0.070 |
Why?
| | Chemokine CX3CL1 | 2 | 2018 | 9 | 0.070 |
Why?
| | Creatine Kinase | 2 | 2017 | 30 | 0.070 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2017 | 70 | 0.070 |
Why?
| | Leg | 2 | 2017 | 123 | 0.070 |
Why?
| | Infant, Newborn | 2 | 2024 | 2780 | 0.070 |
Why?
| | Diffusion Tensor Imaging | 2 | 2017 | 92 | 0.060 |
Why?
| | Infant | 2 | 2024 | 3601 | 0.060 |
Why?
| | Parenteral Nutrition | 1 | 2024 | 27 | 0.060 |
Why?
| | Micronutrients | 1 | 2023 | 16 | 0.050 |
Why?
| | Polyesters | 1 | 2022 | 8 | 0.050 |
Why?
| | Nutrition Surveys | 1 | 2023 | 111 | 0.050 |
Why?
| | Memory, Short-Term | 1 | 2023 | 73 | 0.050 |
Why?
| | Isotopes | 1 | 2022 | 23 | 0.050 |
Why?
| | Egg Proteins | 1 | 2021 | 18 | 0.050 |
Why?
| | Food, Fortified | 1 | 2021 | 27 | 0.050 |
Why?
| | Basal Metabolism | 1 | 2020 | 32 | 0.050 |
Why?
| | Plant Proteins | 1 | 2021 | 67 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2020 | 18 | 0.040 |
Why?
| | Puberty | 1 | 2020 | 18 | 0.040 |
Why?
| | Growth Differentiation Factors | 1 | 2020 | 2 | 0.040 |
Why?
| | Follistatin | 1 | 2020 | 2 | 0.040 |
Why?
| | Myostatin | 1 | 2020 | 8 | 0.040 |
Why?
| | United States | 2 | 2024 | 4913 | 0.040 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 69 | 0.040 |
Why?
| | Fruit | 1 | 2020 | 114 | 0.040 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2020 | 56 | 0.040 |
Why?
| | Acute Disease | 1 | 2019 | 370 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2019 | 317 | 0.040 |
Why?
| | Sex Factors | 1 | 2020 | 702 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 369 | 0.040 |
Why?
| | Solubility | 1 | 2017 | 72 | 0.040 |
Why?
| | Probiotics | 1 | 2017 | 22 | 0.040 |
Why?
| | Fluid Shifts | 1 | 2016 | 2 | 0.030 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 54 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2016 | 86 | 0.030 |
Why?
| | Physical Exertion | 1 | 2016 | 44 | 0.030 |
Why?
| | Anthropometry | 1 | 2016 | 93 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2017 | 143 | 0.030 |
Why?
| | Recovery of Function | 1 | 2017 | 190 | 0.030 |
Why?
| | Physical Examination | 1 | 2016 | 95 | 0.030 |
Why?
| | Electromyography | 1 | 2016 | 131 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 30 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 383 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2017 | 266 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2017 | 264 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2016 | 562 | 0.030 |
Why?
| | Universities | 1 | 2016 | 170 | 0.030 |
Why?
| | Human Growth Hormone | 1 | 2015 | 50 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2016 | 105 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 432 | 0.030 |
Why?
| | Child, Preschool | 1 | 2023 | 3908 | 0.030 |
Why?
| | Body Weight | 1 | 2016 | 514 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 934 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2017 | 1589 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2016 | 1201 | 0.030 |
Why?
| | Inflammation | 1 | 2017 | 608 | 0.030 |
Why?
| | Apoptosis | 1 | 2018 | 1094 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 1590 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 1534 | 0.020 |
Why?
| | Child | 1 | 2020 | 6877 | 0.020 |
Why?
|
|
Church's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|